Skip to main content
. 2013 Sep 3;8(9):e74670. doi: 10.1371/journal.pone.0074670

Figure 7. QD-IHF analysis of pEGFR and pSTAT3 in tumor tissues.

Figure 7

A and B, Tu212 xenografts were treated with vehicle control, erlotinib (Erlo, 40mg/kg/d), niclosamide (Niclo, 20mg/kg/d) or their combination for 14 days. pEGFR and pSTAT3 were analyzed in tumor tissues at the end of experiments by QD-IHF and quantified as described in “Methods”.